# OnCo record androgen-receptor-positive-tnbc (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/androgen-receptor-positive-tnbc/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "androgen-receptor-positive-tnbc" ;
  schema:name "Androgen receptor-positive triple-negative breast cancer"@en ;
  schema:alternateName "AR-positive TNBC"@en, "AR-positive breast cancer"@en, "Androgen receptor expression in breast cancer"@en, "AR immunohistochemistry 10 percent"@en ;
  schema:description "Some triple-negative breast cancers carry the androgen receptor, the protein that prostate cancer runs on. About one in eight ER-negative cancers stain positive, and in trials the prostate drugs bicalutamide and enzalutamide held the disease for a minority of patients; neither is approved for breast cancer, so this remains a trial question."@en ;
  schema:url <https://onco.cc/terms/androgen-receptor-positive-tnbc/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Androgen_receptor> ;
  schema:citation <https://doi.org/10.1158/1078-0432.ccr-12-3327>, <https://doi.org/10.1200/jco.2016.71.3495>, <https://doi.org/10.1172/jci45014>, <https://doi.org/10.1371/journal.pone.0157368> ;
  onco:tag "breast", "tnbc" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/tnbc-luminal-androgen-receptor/>, <https://onco.cc/cancers/apocrine-carcinoma-breast/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/bicalutamide/>, <https://onco.cc/drugs/enzalutamide/> ;
  onco:terms <https://onco.cc/terms/pcr/> .